Organic Process Research & Development · 2001 · 51 citations · 2 references
PharmacyChemistryMedicinal ChemistryDrug DiscoveryEnzymologySynthetic Medicinal ChemistryChiral SeparationEnzyme InhibitionChiral Product SynthesisEnantioselective Synthesis
This report describes a new convergent, selective, and economical synthesis of DMP 777, 1 ending with the coupling of the chiral β-lactam half of the molecule ( 1 ) to the chiral amine as the isocyanate ( 2 ). Other steps involve the coupling of the β-lactam 3 to the phenolic moiety under phase-transfer conditions, followed by resolution of the resulting piperazine derivative using a chiral acid, and recycling of the undesired enantiomer also under phase-transfer conditions. The chiral amine 4 was produced efficiently starting from ( R )-α-methylbenzylamine and the corresponding butyrophenone.
2